Showing results (161-170 of 822) with videos related to
Sort By:
Pageof 83
Immunology|September 1, 1978
Study of human T and B lymphocytes with heterologous antisera. III. Immunofluorescence studies on tonsil sectionsJ P Lamelin, N Thomasset, C Andre, et al.European Journal of Immunology|February 1, 1997
T cell sensitivity to HLA class I-mediated apoptosis is dependent on interleukin-2 and interleukin-4L Genestier, R Paillot, N Bonnefoy-Berard, et al.Microbios|January 1, 1986
Sequential changes in cytomegalovirus antigenic pattern during infection of renal transplant patientsN Faucon-Biguet, M I Siqueira-Linhares, Y Chardonnet, et al.Molecular Immunology|November 1, 1994
Acylation of the lipid A region of a Klebsiella pneumoniae LPS controls the alternative pathway activation of human complementA Mey, D Ponard, M Colomb, et al.The Journal of Clinical Investigation|July 17, 1998
Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cellsL Genestier, R Paillot, S Fournel, et al.Neuropeptides|May 1, 1991
Characterization of calcitonin gene-related peptide receptors and adenylate cyclase response in the murine macrophage cell line P388 D1J Abello, D Kaiserlian, J C Cuber, et al.Immunobiology|November 1, 1992
Binding of a membrane proteoglycan from Klebsiella pneumoniae and its derivatives to human leukocytesZ Hmama, G Normier, E Kouassi, et al.International Immunology|April 1, 1995
Tumor necrosis factor-alpha up-regulates Bcl-2 expression and decreases calcium-dependent apoptosis in human B cell linesL Genestier, N Bonnefoy-Berard, J P Rouault, et al.Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Improvement of cadaveric renal allograft survival by thoracic duct drainage: relation with T-lymphocyte subset modifications assessed by flow-cytometryM Laville, G Cordier, J Brochier, et al.Scandinavian Journal of Immunology|March 1, 1986
Characterization of monoclonal antihuman-B-cell antibody BL13 as an anti-C3d-receptor (CR2) antibodyJ H Cohen, E Fischer, M D Kazatchkine, et al.Pageof 83